Immediate Impact
38 standout
Citing Papers
CAR T therapies in multiple myeloma: unleashing the future
2024 Standout
Bispecific antibodies: advancing precision oncology
2024 Standout
Works of Stefano Spada being referenced
Efficacy of carfilzomib lenalidomide dexamethasone (KRd) with or without transplantation in newly diagnosed myeloma according to risk status: Results from the FORTE trial.
2019
Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Stefano Spada | 186 | 180 | 127 | 25 | 254 | |
| Miguel Inácio da Silva Filho | 141 | 63 | 74 | 24 | 287 | |
| Etsuko Sekimoto | 159 | 179 | 195 | 21 | 314 | |
| Luísa Viterbo | 155 | 195 | 103 | 18 | 226 | |
| Kiyoshi Okazuka | 159 | 176 | 105 | 36 | 335 | |
| Katarzyna Kapelko‐Słowik | 90 | 82 | 78 | 25 | 322 | |
| Koichi Nakase | 67 | 71 | 55 | 25 | 285 | |
| Nobuya Hiraoka | 75 | 41 | 73 | 22 | 250 | |
| Mohammed A. Aljama | 156 | 97 | 88 | 33 | 239 | |
| Mary‐Margaret Keating | 49 | 68 | 37 | 28 | 167 | |
| Shiori Kinoshita | 144 | 79 | 116 | 33 | 325 |
All Works
Login with ORCID to disown or claim papers
Loading papers...